02348.HK
Dawnrays Pharmaceutical (Holdings) Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 0.92
−1.60%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 3.94x
- P/E 2028E
- 4.27x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 5.13x
- PEG TTM
- —
- Price / book
- 0.34x
- Price / sales
- 1.03x
- Price / cash flow
- 3.12x
Enterprise value
- Enterprise value
- -HKD 484.4M
- EV / sales
- -0.36x
- EV / EBITDA
- -1.14x
- EV / EBIT
- -1.75x
- Market cap
- HKD 1.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026